References
- Lawson TM, Williams BD. Silent myocardial infarction in Wegener's granulomatosis. Br J Rheumatol. 1996;35:188–91.
- Allenbach Y, Seror R, Pagnoux C. High frequency of venous thromboembolic events in Churg—Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients. Ann Rheum Dis. 2009;68: 564–7.
- Merkel PA, Lo GH, Holbrook JT. Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann Intern Med. 2005;142:620–6.
- Stassen PM, Derks RPH, Kallenberg CGM, Stegeman CA. Venous thromboembolism in ANCA-associated vasculitis-inci-dence and risk factors. Rheumatology. 2008;47(4):530–4.
- Weidner S, Hafezi-Rachti S, Rupprecht HD. Thromboembolic events as a complication of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2006;55:146–9.
- von Scheven E, Lu TT, Emery HM, Elder ME, Wara DW. Thrombosis and pediatric Wegener's granulomatosis: acquired and genetic risk factors for hypercoagulability. Arthritis Rheum. 2003;49:862–5.
- Lamprecht P, Ho11-Ulrich K, Wieczorek S. Venous thromboem-bolism in Wegener's granulomatosis. J Rheumatol. 2007;34(12): 2323–6.
- Jennette C, Xiao H, Fal RJ. Pathogenesis of vascular inflamma-tion by anti-neutrophil cytoplasmic antibodies. J Am Soc Neph-rol. 2006;17:1235–42.
- Sebastian JK, Voetsch B, Stone JH. The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulabil-ity among patients with Wegener's granulomatosis and without a history of thrombotic events. J Rheumatol. 2007;34:2446–50.
- Dreyer G, Fan S. Therapeutic implications of coexisting severe pulmonary haemorrhage and pulmonary emboli in a case of Wegener granulomatosis. Am J Kidney Dis. 2099;53(3):e5–8.
- Haydar AA, Goldsmith DJA. Pulmonary embolism—or vasculi-tis? J R Soc Med. 2004;97:27-8.